Stock Events

Stock Events

Keros Therapeutics (KROS) Q2 2024 Earnings

8MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-1.37

-1.32

-1.26

-1.21

Details

Expected EPS

-1.333273

Actual EPS

-1.21

Surprise EPS

0.12

Surprise Percent

+9.25%

Description

Keros Therapeutics (KROS) has reported earnings of -1.21 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.